Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

XQ-870, fibrinogen antagonist presented by DuPont Merck

April 19, 1996

More antiplatelet agents from Thomae

April 19, 1996

Antiplatelet agents emerging from the Thomae pipeline

April 19, 1996

Corvas presents preclinical data for NAPc2

April 19, 1996

First clinical results for CVS-1123

April 19, 1996

SD-998, thrombin inhibitor

April 19, 1996

New series of thrombin inhibitors claimed by Thomae

April 19, 1996

Novel prostaglandin D2 agonists from Glaxo Wellcome

April 12, 1996

XR-300 fibrinogen antagonist in preclinical testing

April 12, 1996

Merck & Co. describes fibrinogen antagonists

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...